{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:54Z","timestamp":1786119414064,"version":"build-2736575974"},"reference-count":114,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/ppo.0b013e3181a39585","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T01:19:34Z","timestamp":1264555174000},"page":"117-123","source":"Crossref","is-referenced-by-count":36,"title":["Current Insight on Trends, Causes, and Mechanisms of Hodgkin\u2019s Lymphoma"],"prefix":"10.1097","volume":"15","author":[{"given":"Neil E.","family":"Caporaso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn R.","family":"Goldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210203","first-page":"69","article-title":"On some morbid experiences of the absorbent glands and spleen.","volume":"17","author":"Hodgkin","year":"1832","journal-title":"Med Chir Trans"},{"key":"R2-5-20210203","first-page":"56","article-title":"Cases of enlargement of the lymphatic glands and spleen (or Hodgkin\u2019s disease), with remarks.","volume":"11","author":"Wilks","year":"1865","journal-title":"Guy\u2019s Hosp Rep"},{"key":"R3-5-20210203","article-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid tissues.","year":"2001"},{"key":"R4-5-20210203","article-title":"Cancer Incidence in Five Continents. Vol. I\u2013VIII. IARC CancerBase No. 7.","author":"Parkin","year":"2005"},{"key":"R5-5-20210203","article-title":"SEER Cancer Statistics Review, 1975\u20132003.","author":"Ries","year":"2006"},{"key":"R6-5-20210203","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0140-6736(94)91114-2","article-title":"Epstein-Barr virus in Hodgkin\u2019s disease and site of origin of tumour.","volume":"343","author":"O\u2019Grady","year":"1994","journal-title":"Lancet"},{"key":"R7-5-20210203","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/S0140-6736(05)66780-3","article-title":"Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin\u2019s lymphoma.","volume":"365","author":"Diepstra","year":"2005","journal-title":"Lancet"},{"key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS.","volume":"108","author":"Biggar","year":"2006","journal-title":"Blood"},{"key":"R9-5-20210203","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/oxfordjournals.annonc.a010570","article-title":"Hodgkin\u2019s disease following solid organ transplantation.","volume":"7","author":"Bierman","year":"1996","journal-title":"Ann Oncol"},{"key":"R10-5-20210203","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1200\/JCO.1999.17.10.3122","article-title":"Increased incidence of Hodgkin\u2019s disease after allogeneic bone marrow transplantation.","volume":"17","author":"Rowlings","year":"1999","journal-title":"J Clin Oncol"},{"key":"R11-5-20210203","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/jnci\/djj361","article-title":"Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.","volume":"98","author":"Landgren","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/jnci\/86.21.1600","article-title":"Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.","volume":"86","author":"Goldgar","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"R13-5-20210203","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/cncr.20189","article-title":"Familial aggregation of Hodgkin lymphoma and related tumors.","volume":"100","author":"Goldin","year":"2004","journal-title":"Cancer"},{"key":"R14-5-20210203","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(01)06721-6","article-title":"Analysis of hereditary component of cancer by use of a familial index by site.","volume":"358","author":"Lindelof","year":"2001","journal-title":"Lancet"},{"key":"R15-5-20210203","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2357::AID-CNCR21>3.0.CO;2-3","article-title":"The incidence of lymphoma in first-degree relatives of patients with Hodgkin\u2019s disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study.","volume":"88","author":"Paltiel","year":"2000","journal-title":"Cancer"},{"key":"R16-5-20210203","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s004390000291","article-title":"A genetic study of Hodgkin\u2019s lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden.","volume":"106","author":"Shugart","year":"2000","journal-title":"Hum Genet"},{"key":"R17-5-20210203","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/(SICI)1097-0215(19970917)72:6<977::AID-IJC10>3.0.CO;2-2","article-title":"Birth order, sibship size and risk of Hodgkin\u2019s disease in children and young adults: a population-based study of 31 million person-years.","volume":"72","author":"Westergaard","year":"1997","journal-title":"Int J Cancer"},{"key":"R18-5-20210203","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/annonc\/mdh132","article-title":"Hodgkin\u2019s lymphoma in Chinese migrants to British Columbia: a 25-year survey.","volume":"15","author":"Au","year":"2004","journal-title":"Ann Oncol"},{"key":"R19-5-20210203","article-title":"Trends In Cancer Incidence in Singapore 1968\u20132002, 6.","author":"Seow","year":"2004"},{"key":"R20-5-20210203","article-title":"Hodgkin\u2019s Disease and Allied Disorders.","author":"Jackson","year":"1947"},{"key":"R21-5-20210203","first-page":"220","article-title":"Hodgkin\u2019s lymphomas: classification, diagnosis, and grading.","volume":"36","author":"Harris","year":"1999","journal-title":"Semin Hematol"},{"key":"R22-5-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood.V11.3.211.211","article-title":"Mortality in relation to histologic type in Hodgkin\u2019s disease.","volume":"11","author":"Smetana","year":"1956","journal-title":"Blood"},{"key":"R23-5-20210203","first-page":"628","article-title":"Significance of tissue lymphocytes in the prognosis of lymphogranulomatosis.","volume":"21","author":"Rosenthal","year":"1936","journal-title":"Arch Path"},{"key":"R24-5-20210203","first-page":"944","article-title":"Relationship of histologic features to clinical stages in Hodgkin\u2019s disease.","volume":"90","author":"Lukes","year":"1963","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"R25-5-20210203","first-page":"1063","article-title":"The pathology and nomenclature of Hodgkin\u2019s disease.","volume":"26","author":"Lukes","year":"1966","journal-title":"Cancer Res"},{"issue":"Suppl 1","key":"R26-5-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/annonc\/11.suppl_1.S3","article-title":"Lymphoma classification\u2014from controversy to consensus: the R.E.A.L. and WHO classification of lymphoid neoplasms.","volume":"11","author":"Harris","year":"2000","journal-title":"Ann Oncol"},{"key":"R27-5-20210203","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood.V94.2.411","article-title":"Reed-Sternberg cell genome expression supports a B-cell lineage.","volume":"94","author":"Cossman","year":"1999","journal-title":"Blood"},{"key":"R28-5-20210203","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1056\/NEJM199904223401604","article-title":"Identification of common germinal-center B-cell precursors in two patients with both Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma.","volume":"340","author":"Brauninger","year":"1999","journal-title":"N Engl J Med"},{"key":"R29-5-20210203","first-page":"45","article-title":"Molecular single cell studies of normal and transformed lymphocytes.","volume":"30","author":"Kuppers","year":"1997","journal-title":"Cancer Surv"},{"key":"R30-5-20210203","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199708143370703","article-title":"Origin of nodular lymphocyte-predominant Hodgkin\u2019s disease from a clonal expansion of highly mutated germinal-center B cells.","volume":"337","author":"Marafioti","year":"1997","journal-title":"N Engl J Med"},{"key":"R31-5-20210203","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","article-title":"Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription.","volume":"95","author":"Marafioti","year":"2000","journal-title":"Blood"},{"key":"R32-5-20210203","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.94.17.9337","article-title":"Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells.","volume":"94","author":"Braeuninger","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-5-20210203","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood.V99.2.409","article-title":"Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry.","volume":"99","author":"Falini","year":"2002","journal-title":"Blood"},{"key":"R34-5-20210203","first-page":"2220","article-title":"Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin\u2019s disease.","volume":"92","author":"Carbone","year":"1998","journal-title":"Blood"},{"key":"R35-5-20210203","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood.V87.2.465.bloodjournal872465","article-title":"Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin\u2019s disease.","volume":"87","author":"Falini","year":"1996","journal-title":"Blood"},{"key":"R36-5-20210203","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.191.2.387","article-title":"Rare occurrence of classical Hodgkin\u2019s disease as a T cell lymphoma.","volume":"191","author":"Muschen","year":"2000","journal-title":"J Exp Med"},{"key":"R37-5-20210203","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1182\/blood.V95.10.3020","article-title":"Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease.","volume":"95","author":"Seitz","year":"2000","journal-title":"Blood"},{"key":"R38-5-20210203","article-title":"Cancer Facts & Figures 2007.","year":"2007"},{"key":"R39-5-20210203","article-title":"Cancer Incidence and Mortality in California by Detailed Race\/Ethnicity, 1988\u20131992.","author":"Perkins","year":"1995"},{"key":"R40-5-20210203","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<1041::AID-CNCR31>3.0.CO;2-5","article-title":"The National Cancer Data Base report on Hodgkin\u2019s disease for 1985\u20131989 and 1990\u20131994.","volume":"83","author":"Kennedy","year":"1998","journal-title":"Cancer"},{"key":"R41-5-20210203","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1200\/JCO.2003.12.086","article-title":"A. Randomized comparison of ABVD and MOPP\/ABV hybrid for the treatment of advanced Hodgkin\u2019s disease: report of an intergroup trial.","volume":"21","author":"Duggan","year":"2003","journal-title":"J Clin Oncol"},{"key":"R42-5-20210203","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM199211193272102","article-title":"Chemotherapy of advanced Hodgkin\u2019s disease with MOPP, ABVD, or MOPP alternating with ABVD.","volume":"327","author":"Canellos","year":"1992","journal-title":"N Engl J Med"},{"key":"R43-5-20210203","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/07357900600981380","article-title":"Could BEACOPP be the new standard for the treatment of advanced Hodgkin\u2019s lymphoma (HL)?","volume":"24","author":"Diehl","year":"2006","journal-title":"Cancer Invest"},{"key":"R44-5-20210203","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0959-8049(97)00119-6","article-title":"Hodgkin\u2019s disease in patients older than 70 years of age: a registry-based analysis.","volume":"33","author":"Forsyth","year":"1997","journal-title":"Eur J Cancer"},{"key":"R45-5-20210203","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/1097-0142(19840515)53:10<2191::AID-CNCR2820531031>3.0.CO;2-0","article-title":"Hodgkin\u2019s disease in the elderly. A series of 30 patients aged older than 70 years.","volume":"53","author":"Eghbali","year":"1984","journal-title":"Cancer"},{"key":"R46-5-20210203","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1097-0142(19840301)53:5<1202::AID-CNCR2820530530>3.0.CO;2-L","article-title":"Prognostic factors in Hodgkin\u2019s disease with special reference to age.","volume":"53","author":"Wedelin","year":"1984","journal-title":"Cancer"},{"key":"R47-5-20210203","first-page":"54","article-title":"Diagnostic and Prognostic Studies in Hodgkin\u2019s Lymphoma.","author":"Landgren","year":"2002"},{"issue":"Suppl","key":"R48-5-20210203","first-page":"5","article-title":"Studies of the prognosis in Hodgkin\u2019s disease.","volume":"245","author":"Westling","year":"1965","journal-title":"Acta Radiol"},{"key":"R49-5-20210203","first-page":"438","article-title":"Hodgkin\u2019s lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis.","volume":"88","author":"Landgren","year":"2003","journal-title":"Haematologica"},{"key":"R50-5-20210203","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2005.11.080","article-title":"Hodgkin\u2019s lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin\u2019s Study Group.","volume":"23","author":"Engert","year":"2005","journal-title":"J Clin Oncol"},{"key":"R51-5-20210203","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/annonc\/mdi023","article-title":"A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin\u2019s disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).","volume":"16","author":"Ballova","year":"2005","journal-title":"Ann Oncol"},{"key":"R52-5-20210203","first-page":"1087","article-title":"Hodgkin\u2019s disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen.","volume":"20","author":"Weekes","year":"2002","journal-title":"J Clin Oncol"},{"key":"R53-5-20210203","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0609.2005.00457.x","article-title":"An international approach to the treatment of Hodgkin\u2019s disease in the elderly: launch of the SHIELD study programme.","author":"Proctor","year":"2005","journal-title":"Eur J Haematol Suppl"},{"key":"R54-5-20210203","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/annonc\/mdl094","article-title":"A population-based cohort study on early-stage Hodgkin lymphoma treated with radiotherapy alone: with special reference to older patients.","volume":"17","author":"Landgren","year":"2006","journal-title":"Ann Oncol"},{"key":"R55-5-20210203","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002770050521","article-title":"Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma, 1993\u20131996.","volume":"78","author":"van Spronsen","year":"1999","journal-title":"Ann Hematol"},{"key":"R56-5-20210203","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/1097-0142(19920815)70:4<830::AID-CNCR2820700418>3.0.CO;2-X","article-title":"Hodgkin disease in the elderly. A registry-based analysis.","volume":"70","author":"Erdkamp","year":"1992","journal-title":"Cancer"},{"key":"R57-5-20210203","first-page":"889","article-title":"Effect of age on therapeutic response and survival in advanced Hodgkin\u2019s disease.","volume":"66","author":"Peterson","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"R58-5-20210203","first-page":"450","article-title":"Results of a low aggressivity chemotherapy regimen (CVP\/CEB) in elderly Hodgkin\u2019s disease patients.","volume":"81","author":"Levis","year":"1996","journal-title":"Haematologica"},{"key":"R59-5-20210203","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0609.1989.tb00268.x","article-title":"Hodgkin\u2019s disease and age.","volume":"43","author":"Specht","year":"1989","journal-title":"Eur J Haematol"},{"key":"R61-5-20210203","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ijc.2910080203","article-title":"Epidemiologic patterns of Hodgkin\u2019s disease.","volume":"8","author":"Correa","year":"1971","journal-title":"Int J Cancer"},{"key":"R62-5-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ijc.2910610204","article-title":"International patterns in the occurrence of Hodgkin\u2019s disease in children and young adult males.","volume":"61","author":"Macfarlane","year":"1995","journal-title":"Int J Cancer"},{"key":"R63-5-20210203","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0277-5379(86)90016-7","article-title":"Hodgkin\u2019s disease in Osaka, Japan (1964\u20131985).","volume":"22","author":"Aozasa","year":"1986","journal-title":"Eur J Cancer Clin Oncol"},{"key":"R64-5-20210203","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2002-02-0634","article-title":"Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors.","volume":"100","author":"Ng","year":"2002","journal-title":"Blood"},{"key":"R65-5-20210203","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","article-title":"Second malignant neoplasms among long-term survivors of Hodgkin\u2019s disease: a population-based evaluation over 25 years.","volume":"20","author":"Dores","year":"2002","journal-title":"J Clin Oncol"},{"key":"R66-5-20210203","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2002.08.021","article-title":"Long-term survival and competing causes of death in patients with early-stage Hodgkin\u2019s disease treated at age 50 or younger.","volume":"20","author":"Ng","year":"2002","journal-title":"J Clin Oncol"},{"key":"R67-5-20210203","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin\u2019s disease.","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"R68-5-20210203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/annonc\/8.suppl_1.S115","article-title":"Hodgkin\u2019s disease: complications of therapy and excess mortality.","volume":"8","author":"Hoppe","year":"1997","journal-title":"Ann Oncol"},{"key":"R69-5-20210203","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","article-title":"Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.","volume":"290","author":"Travis","year":"2003","journal-title":"JAMA"},{"key":"R70-5-20210203","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jnci\/95.13.971","article-title":"Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin\u2019s disease.","volume":"95","author":"van Leeuwen","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R71-5-20210203","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood-2005-04-1535","article-title":"Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors.","volume":"106","author":"Hill","year":"2005","journal-title":"Blood"},{"key":"R72-5-20210203","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/jnci\/dji290","article-title":"Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R73-5-20210203","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/annonc\/mdf289","article-title":"Long-term risk of second malignancy after treatment of Hodgkin\u2019s disease: the influence of treatment, age and follow-up time.","volume":"13","author":"Foss Abrahamsen","year":"2002","journal-title":"Ann Oncol"},{"key":"R74-5-20210203","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","article-title":"Late cardiotoxicity after treatment for Hodgkin lymphoma.","volume":"109","author":"Aleman","year":"2007","journal-title":"Blood"},{"key":"R75-5-20210203","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jnci\/92.18.1522","article-title":"Risk of Hodgkin\u2019s disease and other cancers after infectious mononucleosis.","volume":"92","author":"Hjalgrim","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R76-5-20210203","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00051312","article-title":"Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies\u2014a prospective study.","volume":"4","author":"Lehtinen","year":"1993","journal-title":"Cancer Causes Control"},{"key":"R77-5-20210203","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ijc.2910490313","article-title":"Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin\u2019s lymphoma.","volume":"49","author":"Mueller","year":"1991","journal-title":"Int J Cancer"},{"key":"R78-5-20210203","first-page":"893","article-title":"Cancer Epidemiology and Prevention.","author":"Mueller","year":"1996"},{"key":"R79-5-20210203","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T","article-title":"Epstein-Barr virus-associated Hodgkin\u2019s disease: epidemiologic characteristics in international data.","volume":"70","author":"Glaser","year":"1997","journal-title":"Int J Cancer"},{"key":"R80-5-20210203","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1054\/bjoc.2001.1872","article-title":"South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin\u2019s disease.","volume":"85","author":"Flavell","year":"2001","journal-title":"Br J Cancer"},{"key":"R81-5-20210203","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<186::AID-CNCR30>3.0.CO;2-#","article-title":"Epstein-Barr virus in Hodgkin\u2019s disease patients in Japan.","volume":"77","author":"Tomita","year":"1996","journal-title":"Cancer"},{"key":"R82-5-20210203","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1054\/bjoc.1999.1049","article-title":"Risk factors for Hodgkin\u2019s disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents.","volume":"82","author":"Alexander","year":"2000","journal-title":"Br J Cancer"},{"key":"R83-5-20210203","first-page":"1117","article-title":"Epstein-Barr virus in Hodgkin\u2019s disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection.","volume":"7","author":"Sleckman","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R84-5-20210203","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ijc.10979","article-title":"Hodgkin\u2019s lymphoma and Epstein-Barr virus (EBV): no evidence to support hit-and-run mechanism in cases classified as non-EBV-associated.","volume":"104","author":"Gallagher","year":"2003","journal-title":"Int J Cancer"},{"key":"R85-5-20210203","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/1042819021000037994","article-title":"New candidate virus in association with Hodgkin\u2019s disease.","volume":"44","author":"Benharroch","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"R86-5-20210203","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","article-title":"Spectrum of AIDS-associated malignant disorders.","volume":"351","author":"Goedert","year":"1998","journal-title":"Lancet"},{"key":"R87-5-20210203","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2141.2005.05613.x","article-title":"AIDS-related lymphomas: from pathogenesis to pathology.","volume":"130","author":"Carbone","year":"2005","journal-title":"Br J Haematol"},{"key":"R88-5-20210203","article-title":"Primer on the Rheumatic Diseases.","author":"Klippel","year":"2001"},{"key":"R89-5-20210203","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/03009740252937568","article-title":"Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus.","volume":"31","author":"Bjornadal","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"R90-5-20210203","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome.","volume":"89","author":"Kassan","year":"1978","journal-title":"Ann Intern Med"},{"key":"R91-5-20210203","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0021-9681(78)90071-1","article-title":"Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis.","volume":"31","author":"Isomaki","year":"1978","journal-title":"J Chronic Dis"},{"key":"R92-5-20210203","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.1780400424","article-title":"Non-Hodgkin\u2019s lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus.","volume":"40","author":"Mellemkjaer","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R93-5-20210203","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","article-title":"Incidence of cancer among patients with rheumatoid arthritis.","volume":"85","author":"Gridley","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R94-5-20210203","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.10939","article-title":"Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives.","volume":"48","author":"Ekstrom","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R95-5-20210203","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","article-title":"Risk of malignancy among patients with rheumatic conditions.","volume":"88","author":"Thomas","year":"2000","journal-title":"Int J Cancer"},{"key":"R96-5-20210203","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1054\/bjoc.1999.1104","article-title":"Cancer among children of parents with autoimmune diseases.","volume":"82","author":"Mellemkjaer","year":"2000","journal-title":"Br J Cancer"},{"key":"R97-5-20210203","article-title":"Overview of the Etiology and Epidemiology of Lymphoma. Non-Hodgkin\u2019s Lymphoma.","year":"2004"},{"key":"R98-5-20210203","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jnci\/dji092","article-title":"Re: Familial clustering of Hodgkin lymphoma and multiple sclerosis.","volume":"97","author":"Landgren","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R99-5-20210203","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.","volume":"98","author":"Smedby","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R100-5-20210203","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/aje\/kwi341","article-title":"Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin\u2019s lymphoma: a case-control study.","volume":"162","author":"Engels","year":"2005","journal-title":"Am J Epidemiol"},{"key":"R101-5-20210203","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis.","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"key":"R102-5-20210203","first-page":"233","article-title":"Neoplastic complications of transplantation.","volume":"8","author":"Penn","year":"1993","journal-title":"Semin Respir Infect"},{"key":"R103-5-20210203","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood.V84.4.1005.1005","article-title":"The cellular biology of the Reed-Sternberg cell.","volume":"84","author":"Haluska","year":"1994","journal-title":"Blood"},{"key":"R104-5-20210203","first-page":"1785","article-title":"Hodgkin\u2019s disease after renal transplantation.","volume":"27","author":"Garnier","year":"1995","journal-title":"Transplant Proc"},{"key":"R105-5-20210203","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/jmg.2004.027433","article-title":"A genome screen of families at high risk for Hodgkin lymphoma: evidence for a susceptibility gene on chromosome 4.","volume":"42","author":"Goldin","year":"2005","journal-title":"J Med Genet"},{"key":"R106-5-20210203","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2141.2004.05353.x","article-title":"Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin\u2019s lymphoma.","volume":"128","author":"Cordano","year":"2005","journal-title":"Br J Haematol"},{"key":"R107-5-20210203","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/1055-9965.EPI-06-0446","article-title":"Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.","volume":"15","author":"Cozen","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R108-5-20210203","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/blood-2003-08-2860","article-title":"IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma.","volume":"103","author":"Cozen","year":"2004","journal-title":"Blood"},{"key":"R109-5-20210203","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/oxfordjournals.aje.a116990","article-title":"Reproductive factors in Hodgkin\u2019s disease in women: a review.","volume":"139","author":"Glaser","year":"1994","journal-title":"Am J Epidemiol"},{"key":"R110-5-20210203","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/ije\/25.4.737","article-title":"The importance of childbearing for Hodgkin\u2019s disease: new evidence from incidence and mortality models.","volume":"25","author":"Kravdal","year":"1996","journal-title":"Int J Epidemiol"},{"key":"R111-5-20210203","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ijc.2910550606","article-title":"Hodgkin\u2019s disease: the protective effect of childbearing.","volume":"55","author":"Kravdal","year":"1993","journal-title":"Int J Cancer"},{"key":"R112-5-20210203","article-title":"Cancer Incidence and Mortality in England and Wales: Trends and Risk Factors.","author":"Swerdlow","year":"2001"},{"key":"R113-5-20210203","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00043764-199901000-00007","article-title":"Hodgkin\u2019s disease, work, and the environment. A review.","volume":"41","author":"McCunney","year":"1999","journal-title":"J Occup Environ Med"},{"key":"R114-5-20210203","first-page":"872","article-title":"Cancer Epidemiology and Prevention.","author":"Grufferman","year":"2006"},{"key":"R117-5-20210203","article-title":"GLOBOCAN 2002, Cancer Incidence, Mortality and Prevalence Worldwide, IARC CancerBase No. 5, version 2.0.","author":"Ferlay","year":"2004"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PPO.0b013e3181a39585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:14:33Z","timestamp":1786040073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130404-200904000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0b013e3181a39585","relation":{},"ISSN":["1528-9117"],"issn-type":[{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}